Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021 with Abbott, MAQUET, Medtronic & Terumo Medical Dominating

DUBLIN, December 4, 2017 /PRNewswire/ --

The "Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021" report has been added to Research and Markets' offering.

The global coronary artery bypass grafts (CABG) market to grow at a CAGR of 5.83% during the period 2017-2021.

Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

One trend in the market is rise in medical tourism. Developing nations are slowly transforming into a hub for medical tourism. They are providing medical care at a much lower cost when compared with the developed nations. The improving medical infrastructure in developing nations has boosted the growth of medical tourism.

According to the report, one driver in the market is favorable reimbursement policies. Well-structured reimbursement policies for medical devices have been under consideration by insurance regulatory firms for some time now. These policies are quite favorable for patients in some countries. The change in reimbursement policies will drive the sales of CABG. In APAC, many countries such as Thailand, India, China, and Singapore have increased their GDP spending on public healthcare. With an increased spending on healthcare, the CABG market will grow significantly in the region.

Further, the report states that one challenge in the market is availability of alternate treatments. Primary causes of PVDs are smoking, high blood pressure, diabetes, and high cholesterol. These factors are all mainly related to lifestyle changes. Changes to lifestyle and adoption of healthy habits lead to lowering of lifestyle-related diseases. In some cases, medication can also be used to treat CHDs. For instance, antiplatelet, statins, and beta-blockers and nitrates are used to treat CHDs. Less risky procedures such as balloon angioplasty can be used to treat an affected blood vessel by filling it with air to clear a blockage. Stents are also used to treat clogged arteries. Stents are inserted into the affected area to keep an artery from becoming clogged again.

Key vendors

• Abbott
• MAQUET
• Medtronic
• Terumo Medical

Other prominent vendors

• Boston Scientific
• Dextera Surgical
• Edwards Lifesciences
• Ethicon (a subsidiary of Johnson & Johnson)
• Genesee BioMedical
• Hancock Jaffe Laboratories
• HeartWare
• KARL STORZ
• LivaNova
• Neograft
• NOVADAQ
• Teleflex
• VASOPREP SURGICAL
• Vitalitec

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Application

Part 07: Market Segmentation By Product

Part 08: Market Segmentation By End-Users

Part 09: Regional Landscape

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Vendor Analysis

Part 15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/lfc46l/global_coronary

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]